161 related articles for article (PubMed ID: 20814719)
1. Expression of tenascin-C and its isoforms in the breast.
Guttery DS; Shaw JA; Lloyd K; Pringle JH; Walker RA
Cancer Metastasis Rev; 2010 Dec; 29(4):595-606. PubMed ID: 20814719
[TBL] [Abstract][Full Text] [Related]
2. Association of invasion-promoting tenascin-C additional domains with breast cancers in young women.
Guttery DS; Hancox RA; Mulligan KT; Hughes S; Lambe SM; Pringle JH; Walker RA; Jones JL; Shaw JA
Breast Cancer Res; 2010; 12(4):R57. PubMed ID: 20678196
[TBL] [Abstract][Full Text] [Related]
3. Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms.
Hancox RA; Allen MD; Holliday DL; Edwards DR; Pennington CJ; Guttery DS; Shaw JA; Walker RA; Pringle JH; Jones JL
Breast Cancer Res; 2009; 11(2):R24. PubMed ID: 19405959
[TBL] [Abstract][Full Text] [Related]
4. Changes in tenascin-C isoform expression in invasive and preinvasive breast disease.
Adams M; Jones JL; Walker RA; Pringle JH; Bell SC
Cancer Res; 2002 Jun; 62(11):3289-97. PubMed ID: 12036947
[TBL] [Abstract][Full Text] [Related]
5. Analysis of combinatorial variability reveals selective accumulation of the fibronectin type III domains B and D of tenascin-C in injured brain.
Dobbertin A; Czvitkovich S; Theocharidis U; Garwood J; Andrews MR; Properzi F; Lin R; Fawcett JW; Faissner A
Exp Neurol; 2010 Sep; 225(1):60-73. PubMed ID: 20451518
[TBL] [Abstract][Full Text] [Related]
6. Neural stem/progenitor cells express 20 tenascin C isoforms that are differentially regulated by Pax6.
von Holst A; Egbers U; Prochiantz A; Faissner A
J Biol Chem; 2007 Mar; 282(12):9172-81. PubMed ID: 17264084
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of tenascin-C inhibits breast cancer cells development by cell growth, migration, and adhesion impairment.
Wawrzyniak D; Grabowska M; Głodowicz P; Kuczyński K; Kuczyńska B; Fedoruk-Wyszomirska A; Rolle K
PLoS One; 2020; 15(8):e0237889. PubMed ID: 32817625
[TBL] [Abstract][Full Text] [Related]
8. Involvement of large tenascin-C splice variants in breast cancer progression.
Tsunoda T; Inada H; Kalembeyi I; Imanaka-Yoshida K; Sakakibara M; Okada R; Katsuta K; Sakakura T; Majima Y; Yoshida T
Am J Pathol; 2003 Jun; 162(6):1857-67. PubMed ID: 12759243
[TBL] [Abstract][Full Text] [Related]
9. The Promoting Effect of the Extracellular Matrix Peptide TNIIIA2 Derived from Tenascin-C in Colon Cancer Cell Infiltration.
Suzuki H; Sasada M; Kamiya S; Ito Y; Watanabe H; Okada Y; Ishibashi K; Iyoda T; Yanaka A; Fukai F
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106752
[TBL] [Abstract][Full Text] [Related]
10. Expression of fibronectin isoforms in human breast tissue: production of extra domain A+/extra domain B+ by cancer cells and extra domain A+ by stromal cells.
Matsumoto E; Yoshida T; Kawarada Y; Sakakura T
Jpn J Cancer Res; 1999 Mar; 90(3):320-5. PubMed ID: 10359047
[TBL] [Abstract][Full Text] [Related]
11. Tenascin C is a prognostic determinant and potential cancer-associated fibroblasts marker for breast ductal carcinoma.
Yang Z; Ni W; Cui C; Fang L; Xuan Y
Exp Mol Pathol; 2017 Apr; 102(2):262-267. PubMed ID: 28223108
[TBL] [Abstract][Full Text] [Related]
12. Tenascin-C expression and distribution in cultured human chondrocytes and chondrosarcoma cells.
Ghert MA; Qi WN; Erickson HP; Block JA; Scully SP
J Orthop Res; 2002 Jul; 20(4):834-41. PubMed ID: 12168675
[TBL] [Abstract][Full Text] [Related]
13. Tenascin-C Function in Glioma: Immunomodulation and Beyond.
Yalcin F; Dzaye O; Xia S
Adv Exp Med Biol; 2020; 1272():149-172. PubMed ID: 32845507
[TBL] [Abstract][Full Text] [Related]
14. Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior.
Degen M; Brellier F; Kain R; Ruiz C; Terracciano L; Orend G; Chiquet-Ehrismann R
Cancer Res; 2007 Oct; 67(19):9169-79. PubMed ID: 17909022
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1-dependent tenascin C inclusion in extracellular vesicles is required to promote breast cancer cell malignancy.
Campos A; Burgos-Ravanal R; Lobos-González L; Huilcamán R; González MF; Díaz J; Verschae AC; Acevedo JP; Carrasco M; Sepúlveda F; Jeldes E; Varas-Godoy M; Leyton L; Quest AF
Nanomedicine (Lond); 2023 Oct; 18(23):1651-1668. PubMed ID: 37929694
[TBL] [Abstract][Full Text] [Related]
16. Different Functions of Recombinantly Expressed Domains of Tenascin-C in Glial Scar Formation.
Bijelić D; Adžić M; Perić M; Jakovčevski I; Förster E; Schachner M; Andjus PR
Front Immunol; 2020; 11():624612. PubMed ID: 33679718
[TBL] [Abstract][Full Text] [Related]
17. Biology of Tenascin C and its Role in Physiology and Pathology.
Abedsaeidi M; Hojjati F; Tavassoli A; Sahebkar A
Curr Med Chem; 2024; 31(19):2706-2731. PubMed ID: 37021423
[TBL] [Abstract][Full Text] [Related]
18. Novel Human Tenascin-C Function-Blocking Camel Single Domain Nanobodies.
Dhaouadi S; Ben Abderrazek R; Loustau T; Abou-Faycal C; Ksouri A; Erne W; Murdamoothoo D; Mörgelin M; Kungl A; Jung A; Ledrappier S; Benlasfar Z; Bichet S; Chiquet-Ehrismann R; Hendaoui I; Orend G; Bouhaouala-Zahar B
Front Immunol; 2021; 12():635166. PubMed ID: 33790905
[TBL] [Abstract][Full Text] [Related]
19. Tenascin-C expression and splice variant in habu snake venom-induced glomerulonephritis.
Matsumoto K; Hiraiwa N; Yoshiki A; Ohnishi M; Kusakabe M
Exp Mol Pathol; 2002 Jun; 72(3):186-95. PubMed ID: 12009782
[TBL] [Abstract][Full Text] [Related]
20. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.
Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H
Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
